Repeat Dose Safety Study of NRL-1 in Epilepsy Subjects

Clinical trial NCT02721069 · COMPLETED

Trial details

NCT number: NCT02721069
Sponsor: Neurelis, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Repetitive Seizures Breakthrough Seizures

Start date: 2016-04-11
Primary completion: 2020-06-17
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.